Sapien Valve Keeps Delivering in Jobs for Which It Was Not Designed

We recently published the success of balloon-expandable Sapien valve when used as mitral valve replacement. We now hear about its success as pulmonary valve replacement.

válvula Sapien en posición pulmonar

Previous experiences with this prosthesis for aortic valve replacement have encouraged many operators to attempt fixing other valves. At first, there were exceptional cases considered compassionate treatments. However, experience has accumulated and lead to papers being published.

The acute outcome of pulmonary valve replacement with the Sapien valve is excellent in all types of right ventricular outflow tract, although more cases and longer follow-up are still needed.

There are limited papers on pulmonary valve replacement with Sapien XT or Sapien 3.

Data were collected retrospectively and included in a large multicenter registry of patients who received the XT or S3 as pulmonary valve replacement. Patient and procedure characteristics were analyzed, and so were the short term results, according to the type of right ventricular outflow tract anatomy.


Read also: Sapien 3 Performs Well in “Jobs” for Which It Is Not Designed.


Analysis included 774 patients: 397 (51%) with a native or patched outflow tract, 183 (24%) with a conduit, and 194 (25%) with a bioprosthetic valve.

Sapien 3 was used in 78% of patients, and the remainder received the XT model. Most also received the valve with the biggest diameter (29 mm).

Adverse events were reported in 10% of the population, with no difference between outflow tract anatomy.

About 14 patients underwent emergency surgery, and 9 had a second valve implanted. In 1.7% of cases tricuspid valve injury was documented, and 1.3% of patients had new moderate to severe pulmonary regurgitation not present before implantation.


Read also: Balloon-Expandable Valve Outdoes Itself.


The vast majority of patients was discharged with an excellent valve function, but 8.5% had moderate or greater pulmonary regurgitation or a >40 mmHg gradient.

Median follow-up was 12 months. During follow-up, about 9 patients were diagnosed with endocarditis and 17 underwent surgery or received a new transcatheter replacement.

Conclusion

The short term results for balloon-expandable valve implantation as pulmonary valve replacement are very good in all types of right ventricle outflow tract anatomy.

j-jacc-2020-10-041free

Original Title: Transcatheter Pulmonary Valve Replacement With the Sapien Prosthesis.

Reference: Shabana Shahanavaz et al. J Am Coll Cardiol 2020;76:2847–58.  


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

The Ten Commandments in Adult Congenital Heart Disease

Adult congenital heart disease is a life-long condition that requires appropriate follow-up by experts. Said follow-up is paramount to diagnosing specific and highly variable...

Intervention in Congenital Heart Disease

Watch again our Webinar on Intervention in Congenital Heart Disease on our Youtube channel. What things will I learn if I watch this video? 03:28 -...

Procedural Rescheduling Criteria in the Pandemic Era

Patients with structural heart disease are at higher risk in the face of the new coronavirus infection due to both advanced age and numerous...

Incidence of Cancer in Adult patients with Congenital Heart Disease

Adults with congenital heart disease are exposed to cumulative radiation doses, from multiple catheterization procedures. Seeing as these patients are exposed since early age, the chance of...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

AHA 2024 | VANISH2 Trial

Cardiac defibrillator implants (CDIs) have been shown to improve survival in patients with ischemic cardiomyopathy and ventricular tachycardia (VT). However, approximately one third of...

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...